The U.S. Food and Drug Administration has approved Flibanserin, the first prescription drug to boost sexual drive in women. Developed by a small company in North Carolina called Sprout Pharmaceuticals, Addyi is marketed as a drug for women with hypoactive sex drive disorder that has been rejected twice before.

WSJ’s Mark Kelly reports on the potential side effects and covers the controv...